Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids (SOFIA)
Sonalleve Fibroid Ablation (SOFIA) Study is now recruiting patients at four sites worldwide - including at The University of Chicago. The objective of this clinical trial is to compare the safety and clinical effectiveness of a non-invasive MR-HIFU Fibroid Therapy system for relief from uterine fibroids to the alternative of no treatment. The trial is being conducted for the purposes of regulatory approval in the USA. The SOFIA Study includes pre-or peri-menopausal women between 18-50 years of age suffering from symptomatic uterine fibroids (including heavy menstrual bleeding), who fit the criteria following a medical screening and are willing and able to attend all study visits and complete follow-on materials. Patients will be followed for up to three years after MR-HIFU treatment. For more information please search under the www.clinicaltrials.gov identifier: NCT01504308.
Download the flyer for more details about the clinical trial:
| ||||
|
If you are interested in participating, please contact our research coordinator to find out if you are eligible: |
Ambereen Yousuf, MD
HIFU Coordinator
Office: (773) 702 - 6003
Fax: (773) 702 - 1161
ayousuf@radiology.bsd.uchicago.edu
HIFU Coordinator
Office: (773) 702 - 6003
Fax: (773) 702 - 1161
ayousuf@radiology.bsd.uchicago.edu
